LH Laboratory Corp Of America Holdings

  1. Stocks
  2. Healthcare
  3. NYSE: LH

Price (delayed)

$336.34

Market cap

$27.28B

P/E Ratio

27.64

Dividend/share

$2.88

EPS

$12.17

Enterprise value

$33.9B

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 74
Relative Valuation: Rel. Valuation: 63
Relative Profitability: Rel. Profitability: 59

Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by ...

Highlights
Laboratory Corp Of America Holdings's EPS has increased by 33% YoY and by 7% QoQ
LH's net income is up by 31% YoY and by 6% from the previous quarter
The quick ratio has grown by 16% YoY but it has contracted by 3.8% from the previous quarter
The debt has declined by 7% since the previous quarter but it has increased by 3.4% year-on-year
The price to earnings (P/E) is 12% higher than the last 4 quarters average of 24.6 and 11% higher than the 5-year quarterly average of 24.8
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.labcorp.com
Peers: DGX NEO QGEN IDXX

Key stats

What are the main financial stats of LH

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
1.06%
1 week
5.72%
1 month
20.38%
1 year
21.62%
YTD
34.06%
QTD
20.12%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$14.35B
Gross profit
$4.14B
Operating income
$1.5B
Net income
$1B
Gross margin
28.9%
Net margin
7%
LH's net income is up by 31% YoY and by 6% from the previous quarter
Laboratory Corp Of America Holdings's operating income has increased by 26% YoY and by 4% QoQ
The net margin has increased by 23% year-on-year and by 4.5% since the previous quarter
The operating margin has grown by 18% YoY

Price vs fundamentals

How does LH's price correlate with its fundamentals

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
LH P/E details
P/E
27.64
P/B
3.2
P/S
1.92
EV/EBIT
23.22
EV/EBITDA
14.35
EV/Sales
2.36
Laboratory Corp Of America Holdings's EPS has increased by 33% YoY and by 7% QoQ
The price to earnings (P/E) is 12% higher than the last 4 quarters average of 24.6 and 11% higher than the 5-year quarterly average of 24.8
The P/B is 33% higher than the 5-year quarterly average of 2.4 and 23% higher than the last 4 quarters average of 2.6
LH's price to sales (P/S) is 20% higher than its last 4 quarters average of 1.6 and 13% higher than its 5-year quarterly average of 1.7
LH's revenue is up by 6% year-on-year

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA is up by 29% YoY and by 6% QoQ
LH's ROE is up by 25% YoY and by 6% QoQ
The company's return on invested capital rose by 17% YoY and by 3.3% QoQ
Laboratory Corp Of America Holdings's return on sales has increased by 15% YoY and by 5% QoQ

Dividends

What is LH's dividend history
Dividend details
DPS
$2.88
Dividend yield
0.86%
Payout ratio
23.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 87% greater than its total liabilities
Laboratory Corp Of America Holdings's current ratio has increased by 20% YoY and by 4% from the previous quarter
The quick ratio has grown by 16% YoY but it has contracted by 3.8% from the previous quarter
The debt is 21% smaller than the equity
The debt has declined by 7% since the previous quarter but it has increased by 3.4% year-on-year
LH's debt to equity is down by 4.8% since the previous quarter but it is up by 2.6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.